Japan approves its first Alzheimer’s drug
Japan’s health ministry has approved Leqembi, a drug for Alzheimer’s disease that was jointly developed by Japanese and US pharmaceutical companies.
It is the first drug for treatment of the disease in a country with a rapidly ageing population.
